Berberine possesses muscarinic agonist-like properties in cultured rodent cardiomyocytes

Pharmacological Research

Volumn 63, Issue 4, 2011, Pages 335-340

  Salehi, Satin ^a   Filtz, Theresa M ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Berberine; Muscarinic agonist; Rodent cardiomyocytes

Indexed keywords

ADENOSINE; BERBERINE; BETA ADRENERGIC RECEPTOR; CARBACHOL; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; PERTUSSIS TOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR EFFECT; CELL STRAIN HEK293; CHRONOTROPISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; EMBRYO; FEMALE; HEART CONTRACTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BERBERINE; CELL LINE; CELLS, CULTURED; HUMANS; MICE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; MYOCYTES, CARDIAC; PERTUSSIS TOXIN; RECEPTORS, MUSCARINIC;

EID: 79951812360     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.12.004     Document Type: Article

References (36)

1. A.F. Cicero, and S. Ertek Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results Clin Lipidol 4 2009 553 563
2. C.W. Lau, X.Q. Yao, Z.Y. Chen, W.H. Ko, and Y. Huang Cardiovascular actions of berberine Cardiovasc Drug Rev 19 2001 234 244 (Pubitemid 34019907)
3. J.A. Marin-Neto, B.C. Maciel, A.L. Secches, and L. Gallo Junior Cardiovascular effects of berberine in patients with severe congestive heart failure Clin Cardiol 11 1988 253 260
4. X.H. Zeng, X.J. Zeng, and Y.Y. Li Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 92 2003 173 176
5. W.H. Ko, X.Q. Yao, C.W. Lau, W.I. Law, Z.Y. Chen, and W. Kwok Vasorelaxant and antiproliferative effects of berberine Eur J Pharmacol 399 2000 187 196 (Pubitemid 30407040)
6. E. Olmez, and M. Ilhan Evaluation of the alpha-adrenoceptor antagonistic action of berberine in isolated organs Arzneimittelforschung 42 1992 1095 1097
7. J. Yang, H.D. Wang, D.X. Lu, Y.P. Wang, R.B. Qi, and J. Li Effects of neutral sulfate berberine on LPS-induced cardiomyocyte TNF-alpha secretion, abnormal calcium cycling, and cardiac dysfunction in rats Acta Pharmacol Sin 27 2006 173 178 (Pubitemid 43171155)
8. F. Riccioppo Neto Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit Br J Pharmacol 108 1993 534 537 (Pubitemid 23032566)
9. Y.X. Wang, and Y.M. Zheng Ionic mechanism responsible for prolongation of cardiac action-potential duration by berberine J Cardiovasc Pharmacol 30 1997 214 222
10. E.Y. Eaker, and C.A. Sninsky Effect of berberine on myoelectric activity and transit of the small intestine in rats Gastroenterology 96 1989 1506 1513 (Pubitemid 19138693)
11. L. Zhou, X. Wang, Y. Yang, L. Wu, F. Li, and R. Zhang Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes Biochim Biophys Acta 2010 10.1016/j.bbadis.2010.10.001
12. J. Zhou, and S. Zhou Berberine regulates peroxisome proliferator- activated receptors and positive transcription elongation factor b expression in diabetic adipocytes Eur J Pharmacol 649 2010 390 397
13. B.X. Li, B.F. Yang, J. Zhou, C.Q. Xu, and Y.R. Li Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes Acta Pharmacol Sin 22 2001 125 131 (Pubitemid 32158350)
14. + channels in cardiac myocytes Eur J Pharmacol 316 1996 307 315
15. S.N. Wu, H.S. Yu, C.R. Jan, H.F. Li, and C.L. Yu Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells Life Sci 62 1998 2283 2294 (Pubitemid 28273157)
16. C-S. Jang The action of berberine on mammalian hearts J Pharmacol Exp Ther 71 1941 178 186
17. M. Sabir, and N.K. Bhide Study of some pharmacological actions of berberine Indian J Physiol Pharmacol 15 1971 111 132
18. J.E. Shaffer Inotropic and chronotropic activity of berberine on isolated guinea pig atria J Cardiovasc Pharmacol 7 1985 307 315 (Pubitemid 15083828)
19. S. Dhein, C.J. van Koppen, and O.E. Brodde Muscarinic receptors in the mammalian heart Pharmacol Res 44 2001 161 182 (Pubitemid 32889460)
20. T. Schmeller, B. Latz-Bruning, and M. Wink Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores Phytochemistry 44 1997 257 266 (Pubitemid 27087925)
21. W.H. Peng, M.T. Hsieh, and C.R. Wu Effect of long-term administration of berberine on scopolamine-induced amnesia in rats Jpn J Pharmacol 74 1997 261 266
22. D.H. Shin, H. Yu, and W.H. Hsu A paradoxical stimulatory effect of berberine on guinea-pig ileum contractility: possible involvement of acetylcholine release from the postganglionic parasympathetic nerve and cholinesterase inhibition Life Sci 53 1993 1495 1500
23. M. Toraason, M.E. Luken, M. Breitenstein, J.A. Krueger, and R.E. Biagini Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart Toxicology 56 1989 107 117 (Pubitemid 19128869)
24. 2 toxicity Am J Physiol 276 1999 H167 H175
25. S.R. Long, R.A. Carey, K.M. Crofoot, P.J. Proteau, and T.M. Filtz Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay Phytomedicine 13 2006 643 650 (Pubitemid 44666402)
26. M. Rashid, H.A. Muntasir, M. Watanabe, M. Nakazawa, M. Ozaki, and T. Nagatomo Assessment of affinities and dissociation potencies of several 5-HT2 antagonists to and from M2 muscarinic receptor in rat heart membranes Biol Pharm Bull 26 2003 1184 1187 (Pubitemid 40012588)
27. Y. Zhang, W.K. Vogel, J.S. McCullar, J.A. Greenwood, and T.M. Filtz Phospholipase C-beta3 and -beta1 form homodimers, but not heterodimers, through catalytic and carboxyl-terminal domains Mol Pharmacol 70 2006 860 868 (Pubitemid 44268443)
28. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
29. G.L. Peterson Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall Anal Biochem 100 1979 201 220 (Pubitemid 10183864)
30. M. Rashid, M. Watanabe, M. Nakazawa, T. Nakamura, K. Hattori, and T. Nagatom Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists Jpn J Pharmacol 87 2001 189 194
31. A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res 60 2003 478 487 (Pubitemid 37501105)
32. R.A. Evans, M. Watson, H.I. Yamamura, and W.R. Roeske Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart J Pharmacol Exp Ther 235 1985 612 618 (Pubitemid 16210724)
33. F. Heitz, J.A. Holzwarth, J.P. Gies, R.M. Pruss, S. Trumpp-Kallmeyer, and M.F. Hibert Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site Eur J Pharmacol 380 1999 183 195 (Pubitemid 29469529)
34. K. Ponicke, I. Heinroth-Hoffmann, and O.E. Brodde Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats Br J Pharmacol 138 2003 156 160 (Pubitemid 36194215)
35. Z. Wang, H. Shi, and H. Wang Functional M3 muscarinic acetylcholine receptors in mammalian hearts Br J Pharmacol 142 2004 395 408 (Pubitemid 38869852)
36. D.S. Koh, and B. Hille Modulation by neurotransmitters of catecholamine secretion from sympathetic ganglion neurons detected by amperometry Proc Natl Acad Sci USA 94 1997 1506 1511 (Pubitemid 27087881)